Dr. David Chand
MD & CEO
Notable Quotes
We have a very strong growth both on the balance sheet and also on the profit and loss.
The only scope for us to realign the asset pricing right... there is a scope for realigning that portfolio and that is what actually our strategy to look into those pricing very closely.
Unless and until we compute fully on that it's not proper to quantify that at this stage.